Stock Events

Acadia Pharmaceuticals (ACAD.MX) Q4 2023 Earnings

2NovConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-7.89
-5.21
-2.52
0.17

Details

Expected EPS
-7.892851500000001
Actual EPS
-7.015868000000001
Surprise EPS
0.88
Surprise Percent
+11.11%

Description

Acadia Pharmaceuticals (ACAD.MX) has reported earnings of -7.015868000000001 per share for Q4 2023.

0 Comments

Share your thoughts